NoScore ESG

We equip You with the underlying data and analysis tools to navigate ESG.

Power Your:

SMA Construction

Equip your analysts with all the data they need to customize SMAs for institutional clients according to their specific values.

Pay flat fees of $9,999/seat -- no basis points.

Let's talk ➝

Direct Custom Indexing

Leverage our APIs to power the ESG experience for your in-house Direct Custom Indexing solution. Accelerate your development and provide best-in-class data and reporting to your clients.

Let's talk➝

Index Product Creation

Launch an ETF! Express your thesis leveraging our data, and/or bring your own data and we'll handle the data processing and upkeep for you.

Let's Talk ➝

Request Trial Access

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

The Problem with ESG Scores

The notion that someone, or team of experts, can reduce the complexity of ESG into a single score is tempting. Until you see a score that surprises you. And then you spend your analysts' time trying to reverse-engineer why. What data were they looking at, and to what extent does the score reflect opinion? This repeats for each of the many ratings vendors.

Meanwhile, under cover of complexity and black boxes, companies and funds are impact-washing. And regulators are taking note.

Create Thematic Indices

We have experience working with partners to launch successful funds..

Customers Love Us

"We continue to be extremely impressed by the rate of iteration of the tool and your responsiveness to our requests, we are very excited to continue our partnership with YourStake.


Enterprise Partner, Minnesota

"We can't find this level of transparency anywhere. We love how YourStake shows us exactly where each company in our portfolios is releasing toxic air pollution, and you show the methodology for how you translate that to real world impact."

Institutional Partner, New York
#1 Rated ESG/SRI Analysis tool in the T3 and Inside Information Advisor Software Survey (March 2021)